StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2023, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 11 Sep 2023 20:00:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday SAFE SUPPLY AND ORIGIN THERAPEUTICS RECEIVE CONDITIONAL APPROVAL FOR LISTING ON THE CSE http://www.streetinsider.com/Press+Releases/SAFE+SUPPLY+AND+ORIGIN+THERAPEUTICS+RECEIVE+CONDITIONAL+APPROVAL+FOR+LISTING+ON+THE+CSE/22149182.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/SAFE+SUPPLY+AND+ORIGIN+THERAPEUTICS+RECEIVE+CONDITIONAL+APPROVAL+FOR+LISTING+ON+THE+CSE/22149182.html for the full story. http://www.streetinsider.com/Press+Releases/SAFE+SUPPLY+AND+ORIGIN+THERAPEUTICS+RECEIVE+CONDITIONAL+APPROVAL+FOR+LISTING+ON+THE+CSE/22149182.html Mon, 11 Sep 2023 20:00:00 -0500 O.54468293 ORIG U8B SAFE SUPPLY AND ORIGIN THERAPEUTICS RECEIVE CONDITIONAL APPROVAL FOR LISTING ON THE CSE http://www.streetinsider.com/Press+Releases/SAFE+SUPPLY+AND+ORIGIN+THERAPEUTICS+RECEIVE+CONDITIONAL+APPROVAL+FOR+LISTING+ON+THE+CSE/22149182.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/SAFE+SUPPLY+AND+ORIGIN+THERAPEUTICS+RECEIVE+CONDITIONAL+APPROVAL+FOR+LISTING+ON+THE+CSE/22149182.html for the full story. http://www.streetinsider.com/Press+Releases/SAFE+SUPPLY+AND+ORIGIN+THERAPEUTICS+RECEIVE+CONDITIONAL+APPROVAL+FOR+LISTING+ON+THE+CSE/22149182.html Mon, 11 Sep 2023 20:00:00 -0500 O.54468293 ORIG U8B SAFE SUPPLY AND ORIGIN THERAPEUTICS RECEIVE CONDITIONAL APPROVAL FOR LISTING ON THE CSE http://www.streetinsider.com/Press+Releases/SAFE+SUPPLY+AND+ORIGIN+THERAPEUTICS+RECEIVE+CONDITIONAL+APPROVAL+FOR+LISTING+ON+THE+CSE/22149182.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/SAFE+SUPPLY+AND+ORIGIN+THERAPEUTICS+RECEIVE+CONDITIONAL+APPROVAL+FOR+LISTING+ON+THE+CSE/22149182.html for the full story. http://www.streetinsider.com/Press+Releases/SAFE+SUPPLY+AND+ORIGIN+THERAPEUTICS+RECEIVE+CONDITIONAL+APPROVAL+FOR+LISTING+ON+THE+CSE/22149182.html Mon, 11 Sep 2023 20:00:00 -0500 O.54468293 ORIG U8B SAFE SUPPLY AND ORIGIN THERAPEUTICS RECEIVE CONDITIONAL APPROVAL FOR LISTING ON THE CSE http://www.streetinsider.com/Globe+Newswire/SAFE+SUPPLY+AND+ORIGIN+THERAPEUTICS+RECEIVE+CONDITIONAL+APPROVAL+FOR+LISTING+ON+THE+CSE/22149182.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/SAFE+SUPPLY+AND+ORIGIN+THERAPEUTICS+RECEIVE+CONDITIONAL+APPROVAL+FOR+LISTING+ON+THE+CSE/22149182.html for the full story. http://www.streetinsider.com/Globe+Newswire/SAFE+SUPPLY+AND+ORIGIN+THERAPEUTICS+RECEIVE+CONDITIONAL+APPROVAL+FOR+LISTING+ON+THE+CSE/22149182.html Mon, 11 Sep 2023 20:00:00 -0500 O.54468293 ORIG U8B SAFE SUPPLY AND ORIGIN THERAPEUTICS RECEIVE CONDITIONAL APPROVAL FOR LISTING ON THE CSE http://www.streetinsider.com/Globe+Newswire/SAFE+SUPPLY+AND+ORIGIN+THERAPEUTICS+RECEIVE+CONDITIONAL+APPROVAL+FOR+LISTING+ON+THE+CSE/22149182.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/SAFE+SUPPLY+AND+ORIGIN+THERAPEUTICS+RECEIVE+CONDITIONAL+APPROVAL+FOR+LISTING+ON+THE+CSE/22149182.html for the full story. http://www.streetinsider.com/Globe+Newswire/SAFE+SUPPLY+AND+ORIGIN+THERAPEUTICS+RECEIVE+CONDITIONAL+APPROVAL+FOR+LISTING+ON+THE+CSE/22149182.html Mon, 11 Sep 2023 20:00:00 -0500 O.54468293 ORIG U8B SAFE SUPPLY AND ORIGIN THERAPEUTICS RECEIVE CONDITIONAL APPROVAL FOR LISTING ON THE CSE http://www.streetinsider.com/Globe+Newswire/SAFE+SUPPLY+AND+ORIGIN+THERAPEUTICS+RECEIVE+CONDITIONAL+APPROVAL+FOR+LISTING+ON+THE+CSE/22149182.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/SAFE+SUPPLY+AND+ORIGIN+THERAPEUTICS+RECEIVE+CONDITIONAL+APPROVAL+FOR+LISTING+ON+THE+CSE/22149182.html for the full story. http://www.streetinsider.com/Globe+Newswire/SAFE+SUPPLY+AND+ORIGIN+THERAPEUTICS+RECEIVE+CONDITIONAL+APPROVAL+FOR+LISTING+ON+THE+CSE/22149182.html Mon, 11 Sep 2023 20:00:00 -0500 O.54468293 ORIG U8B Origin Therapeutics Announces Results of Annual General and Special Meeting of Shareholders http://www.streetinsider.com/Press+Releases/Origin+Therapeutics+Announces+Results+of+Annual+General+and+Special+Meeting+of+Shareholders/22126554.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Origin+Therapeutics+Announces+Results+of+Annual+General+and+Special+Meeting+of+Shareholders/22126554.html for the full story. http://www.streetinsider.com/Press+Releases/Origin+Therapeutics+Announces+Results+of+Annual+General+and+Special+Meeting+of+Shareholders/22126554.html Tue, 05 Sep 2023 15:57:00 -0500 O.54468293 ORIG Origin Therapeutics Announces Results of Annual General and Special Meeting of Shareholders http://www.streetinsider.com/Press+Releases/Origin+Therapeutics+Announces+Results+of+Annual+General+and+Special+Meeting+of+Shareholders/22126554.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Origin+Therapeutics+Announces+Results+of+Annual+General+and+Special+Meeting+of+Shareholders/22126554.html for the full story. http://www.streetinsider.com/Press+Releases/Origin+Therapeutics+Announces+Results+of+Annual+General+and+Special+Meeting+of+Shareholders/22126554.html Tue, 05 Sep 2023 15:57:00 -0500 O.54468293 ORIG Origin Therapeutics Announces Results of Annual General and Special Meeting of Shareholders http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics+Announces+Results+of+Annual+General+and+Special+Meeting+of+Shareholders/22126554.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics+Announces+Results+of+Annual+General+and+Special+Meeting+of+Shareholders/22126554.html for the full story. http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics+Announces+Results+of+Annual+General+and+Special+Meeting+of+Shareholders/22126554.html Tue, 05 Sep 2023 15:57:00 -0500 O.54468293 ORIG Origin Therapeutics Announces Results of Annual General and Special Meeting of Shareholders http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics+Announces+Results+of+Annual+General+and+Special+Meeting+of+Shareholders/22126554.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics+Announces+Results+of+Annual+General+and+Special+Meeting+of+Shareholders/22126554.html for the full story. http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics+Announces+Results+of+Annual+General+and+Special+Meeting+of+Shareholders/22126554.html Tue, 05 Sep 2023 15:57:00 -0500 O.54468293 ORIG Origin Therapeutics Announces New Director http://www.streetinsider.com/Press+Releases/Origin+Therapeutics+Announces+New+Director/20772388.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Origin+Therapeutics+Announces+New+Director/20772388.html for the full story. http://www.streetinsider.com/Press+Releases/Origin+Therapeutics+Announces+New+Director/20772388.html Mon, 31 Oct 2022 19:00:00 -0500 O.54468293 ORIG Origin Therapeutics Announces New Director http://www.streetinsider.com/Press+Releases/Origin+Therapeutics+Announces+New+Director/20772388.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Origin+Therapeutics+Announces+New+Director/20772388.html for the full story. http://www.streetinsider.com/Press+Releases/Origin+Therapeutics+Announces+New+Director/20772388.html Mon, 31 Oct 2022 19:00:00 -0500 O.54468293 ORIG Origin Therapeutics Announces New Director http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics+Announces+New+Director/20772388.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics+Announces+New+Director/20772388.html for the full story. http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics+Announces+New+Director/20772388.html Mon, 31 Oct 2022 19:00:00 -0500 O.54468293 ORIG Origin Therapeutics Announces New Director http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics+Announces+New+Director/20772388.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics+Announces+New+Director/20772388.html for the full story. http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics+Announces+New+Director/20772388.html Mon, 31 Oct 2022 19:00:00 -0500 O.54468293 ORIG Origin Therapeutics’ Portfolio Company, Clairvoyant, Approved for Phase 2 Psilocybin Therapy Trial; First Clinical Site Initiated in Finland http://www.streetinsider.com/Press+Releases/Origin+Therapeutics%E2%80%99+Portfolio+Company%2C+Clairvoyant%2C+Approved+for+Phase+2+Psilocybin+Therapy+Trial%3B+First+Clinical+Site+Initiated+in+Finland/20717308.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Origin+Therapeutics%E2%80%99+Portfolio+Company%2C+Clairvoyant%2C+Approved+for+Phase+2+Psilocybin+Therapy+Trial%3B+First+Clinical+Site+Initiated+in+Finland/20717308.html for the full story. http://www.streetinsider.com/Press+Releases/Origin+Therapeutics%E2%80%99+Portfolio+Company%2C+Clairvoyant%2C+Approved+for+Phase+2+Psilocybin+Therapy+Trial%3B+First+Clinical+Site+Initiated+in+Finland/20717308.html Tue, 18 Oct 2022 18:00:00 -0500 A.28748976 O.20982957 O.54468293 ORIG Origin Therapeutics’ Portfolio Company, Clairvoyant, Approved for Phase 2 Psilocybin Therapy Trial; First Clinical Site Initiated in Finland http://www.streetinsider.com/Press+Releases/Origin+Therapeutics%E2%80%99+Portfolio+Company%2C+Clairvoyant%2C+Approved+for+Phase+2+Psilocybin+Therapy+Trial%3B+First+Clinical+Site+Initiated+in+Finland/20717308.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Origin+Therapeutics%E2%80%99+Portfolio+Company%2C+Clairvoyant%2C+Approved+for+Phase+2+Psilocybin+Therapy+Trial%3B+First+Clinical+Site+Initiated+in+Finland/20717308.html for the full story. http://www.streetinsider.com/Press+Releases/Origin+Therapeutics%E2%80%99+Portfolio+Company%2C+Clairvoyant%2C+Approved+for+Phase+2+Psilocybin+Therapy+Trial%3B+First+Clinical+Site+Initiated+in+Finland/20717308.html Tue, 18 Oct 2022 18:00:00 -0500 A.28748976 O.20982957 O.54468293 ORIG Origin Therapeutics’ Portfolio Company, Clairvoyant, Approved for Phase 2 Psilocybin Therapy Trial; First Clinical Site Initiated in Finland http://www.streetinsider.com/Press+Releases/Origin+Therapeutics%E2%80%99+Portfolio+Company%2C+Clairvoyant%2C+Approved+for+Phase+2+Psilocybin+Therapy+Trial%3B+First+Clinical+Site+Initiated+in+Finland/20717308.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Origin+Therapeutics%E2%80%99+Portfolio+Company%2C+Clairvoyant%2C+Approved+for+Phase+2+Psilocybin+Therapy+Trial%3B+First+Clinical+Site+Initiated+in+Finland/20717308.html for the full story. http://www.streetinsider.com/Press+Releases/Origin+Therapeutics%E2%80%99+Portfolio+Company%2C+Clairvoyant%2C+Approved+for+Phase+2+Psilocybin+Therapy+Trial%3B+First+Clinical+Site+Initiated+in+Finland/20717308.html Tue, 18 Oct 2022 18:00:00 -0500 A.28748976 O.20982957 O.54468293 ORIG Origin Therapeutics’ Portfolio Company, Clairvoyant, Approved for Phase 2 Psilocybin Therapy Trial; First Clinical Site Initiated in Finland http://www.streetinsider.com/Press+Releases/Origin+Therapeutics%E2%80%99+Portfolio+Company%2C+Clairvoyant%2C+Approved+for+Phase+2+Psilocybin+Therapy+Trial%3B+First+Clinical+Site+Initiated+in+Finland/20717308.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Origin+Therapeutics%E2%80%99+Portfolio+Company%2C+Clairvoyant%2C+Approved+for+Phase+2+Psilocybin+Therapy+Trial%3B+First+Clinical+Site+Initiated+in+Finland/20717308.html for the full story. http://www.streetinsider.com/Press+Releases/Origin+Therapeutics%E2%80%99+Portfolio+Company%2C+Clairvoyant%2C+Approved+for+Phase+2+Psilocybin+Therapy+Trial%3B+First+Clinical+Site+Initiated+in+Finland/20717308.html Tue, 18 Oct 2022 18:00:00 -0500 A.28748976 O.20982957 O.54468293 ORIG Origin Therapeutics’ Portfolio Company, Clairvoyant, Approved for Phase 2 Psilocybin Therapy Trial; First Clinical Site Initiated in Finland http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics%E2%80%99+Portfolio+Company%2C+Clairvoyant%2C+Approved+for+Phase+2+Psilocybin+Therapy+Trial%3B+First+Clinical+Site+Initiated+in+Finland/20717308.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics%E2%80%99+Portfolio+Company%2C+Clairvoyant%2C+Approved+for+Phase+2+Psilocybin+Therapy+Trial%3B+First+Clinical+Site+Initiated+in+Finland/20717308.html for the full story. http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics%E2%80%99+Portfolio+Company%2C+Clairvoyant%2C+Approved+for+Phase+2+Psilocybin+Therapy+Trial%3B+First+Clinical+Site+Initiated+in+Finland/20717308.html Tue, 18 Oct 2022 18:00:00 -0500 A.28748976 O.20982957 O.54468293 ORIG Origin Therapeutics’ Portfolio Company, Clairvoyant, Approved for Phase 2 Psilocybin Therapy Trial; First Clinical Site Initiated in Finland http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics%E2%80%99+Portfolio+Company%2C+Clairvoyant%2C+Approved+for+Phase+2+Psilocybin+Therapy+Trial%3B+First+Clinical+Site+Initiated+in+Finland/20717308.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics%E2%80%99+Portfolio+Company%2C+Clairvoyant%2C+Approved+for+Phase+2+Psilocybin+Therapy+Trial%3B+First+Clinical+Site+Initiated+in+Finland/20717308.html for the full story. http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics%E2%80%99+Portfolio+Company%2C+Clairvoyant%2C+Approved+for+Phase+2+Psilocybin+Therapy+Trial%3B+First+Clinical+Site+Initiated+in+Finland/20717308.html Tue, 18 Oct 2022 18:00:00 -0500 A.28748976 O.20982957 O.54468293 ORIG Origin Therapeutics’ Portfolio Company, Clairvoyant, Approved for Phase 2 Psilocybin Therapy Trial; First Clinical Site Initiated in Finland http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics%E2%80%99+Portfolio+Company%2C+Clairvoyant%2C+Approved+for+Phase+2+Psilocybin+Therapy+Trial%3B+First+Clinical+Site+Initiated+in+Finland/20717308.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics%E2%80%99+Portfolio+Company%2C+Clairvoyant%2C+Approved+for+Phase+2+Psilocybin+Therapy+Trial%3B+First+Clinical+Site+Initiated+in+Finland/20717308.html for the full story. http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics%E2%80%99+Portfolio+Company%2C+Clairvoyant%2C+Approved+for+Phase+2+Psilocybin+Therapy+Trial%3B+First+Clinical+Site+Initiated+in+Finland/20717308.html Tue, 18 Oct 2022 18:00:00 -0500 A.28748976 O.20982957 O.54468293 ORIG Origin Therapeutics’ Portfolio Company, Clairvoyant, Approved for Phase 2 Psilocybin Therapy Trial; First Clinical Site Initiated in Finland http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics%E2%80%99+Portfolio+Company%2C+Clairvoyant%2C+Approved+for+Phase+2+Psilocybin+Therapy+Trial%3B+First+Clinical+Site+Initiated+in+Finland/20717308.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics%E2%80%99+Portfolio+Company%2C+Clairvoyant%2C+Approved+for+Phase+2+Psilocybin+Therapy+Trial%3B+First+Clinical+Site+Initiated+in+Finland/20717308.html for the full story. http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics%E2%80%99+Portfolio+Company%2C+Clairvoyant%2C+Approved+for+Phase+2+Psilocybin+Therapy+Trial%3B+First+Clinical+Site+Initiated+in+Finland/20717308.html Tue, 18 Oct 2022 18:00:00 -0500 A.28748976 O.20982957 O.54468293 ORIG Origin Therapeutics Announces Director Resignation http://www.streetinsider.com/Press+Releases/Origin+Therapeutics+Announces+Director+Resignation/20658681.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Origin+Therapeutics+Announces+Director+Resignation/20658681.html for the full story. http://www.streetinsider.com/Press+Releases/Origin+Therapeutics+Announces+Director+Resignation/20658681.html Mon, 03 Oct 2022 23:59:00 -0500 O.54468293 ORIG Origin Therapeutics Announces Director Resignation http://www.streetinsider.com/Press+Releases/Origin+Therapeutics+Announces+Director+Resignation/20658681.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Origin+Therapeutics+Announces+Director+Resignation/20658681.html for the full story. http://www.streetinsider.com/Press+Releases/Origin+Therapeutics+Announces+Director+Resignation/20658681.html Mon, 03 Oct 2022 23:59:00 -0500 O.54468293 ORIG Origin Therapeutics Announces Director Resignation http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics+Announces+Director+Resignation/20658681.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics+Announces+Director+Resignation/20658681.html for the full story. http://www.streetinsider.com/Globe+Newswire/Origin+Therapeutics+Announces+Director+Resignation/20658681.html Mon, 03 Oct 2022 23:59:00 -0500 O.54468293 ORIG